Cargando…
Therapeutic Vaccines and Cancer Immunotherapy
Autores principales: | Bhatt, Darshak, Daemen, Toos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711462/ https://www.ncbi.nlm.nih.gov/pubmed/33050488 http://dx.doi.org/10.3390/vaccines8040596 |
Ejemplares similares
-
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis
por: Bhatt, Darshak K., et al.
Publicado: (2021) -
Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cells
por: Bhatt, Darshak Kartikey, et al.
Publicado: (2022) -
A systematic analysis on the clinical safety and efficacy of onco-virotherapy
por: Bhatt, Darshak K., et al.
Publicado: (2021) -
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015) -
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus‐related hepatocellular carcinoma
por: Chen, Shipeng, et al.
Publicado: (2022)